<DOC>
	<DOCNO>NCT00661479</DOCNO>
	<brief_summary>This exploratory , 12-month , ascending-dose study evaluate safety effect visual function single injection Brimonidine intravitreal implant one eye patient Retinitis Pigmentosa .</brief_summary>
	<brief_title>An Exploratory Study Evaluate Safety Brimonidine Intravitreal Implant Patients With Retinitis Pigmentosa</brief_title>
	<detailed_description />
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<criteria>Retinitis Pigmentosa eye Visual acuity 20/40 count finger Growth new blood vessel eye Any intraocular surgery laser either eye last 6 month prior Screening visit Screening visit Day 1 Any ocular disease interfere diagnosis assessment disease progression Significant nearsightedness HIV Female patient pregnant , nursing , plan pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>